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Destabilization of nucleophosmin mRNA by the
HuR/KSRP complex is required for muscle ﬁbre
formation
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Matteo Giovarelli7, Roberto Gherzi7, Sergio Di Marco1 & Imed-Eddine Gallouzi1
HuR promotes myogenesis by stabilizing the MyoD, myogenin and p21 mRNAs during the
fusion of muscle cells to form myotubes. Here we show that HuR, via a novel mRNA
destabilizing activity, promotes the early steps of myogenesis by reducing the expression of
the cell cycle promoter nucleophosmin (NPM). Depletion of HuR stabilizes the NPM mRNA,
increases NPM protein levels and inhibits myogenesis, while its overexpression elicits the
opposite effects. NPM mRNA destabilization involves the association of HuR with the decay
factor KSRP as well as the ribonuclease PARN and the exosome. The C terminus of HuR
mediates the formation of the HuR–KSRP complex and is sufﬁcient for maintaining a low level
of the NPM mRNA as well as promoting the commitment of muscle cells to myogenesis. We
therefore propose a model whereby the downregulation of the NPMmRNA, mediated by HuR,
KSRP and its associated ribonucleases, is required for proper myogenesis.
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M
uscle differentiation, also known as myogenesis,
represents a vital process that is activated during
embryogenesis and in response to injury to promote
the formation of muscle ﬁbres1,2. Myogenesis requires the
activation of muscle-speciﬁc promyogenic factors that are
expressed at speciﬁc steps of the myogenic process and act in a
sequential manner. We and others have demonstrated that the
expression of genes encoding some of these promyogenic factors
such as MyoD, myogenin and the cyclin-dependent kinase p21
are not only regulated at the transcriptional level but are also
modulated posttranscriptionally3–8. Indeed, modulating the
half-lives of these mRNAs plays an important role in their
expression. The RNA-binding protein HuR, via its ability to
bind speciﬁc AU-rich elements (AREs) in the 30-untranslated
regions (30-UTRs) of these mRNAs, protects them from the
AU-rich-mediated decay machinery4,5,7–9. This HuR-mediated
stabilization represents a key regulatory step that is required
for the expression of these promyogenic factors and proper
myogenesis.
HuR, a member of the ELAV family of RNA-binding proteins,
speciﬁcally binds to AREs located in the 30-UTRs of its target
transcripts8–12 leading to their stability that in turn enhances the
expression of the encoded proteins5,7. In addition to mRNA
stability, HuR modulates the nucleocytoplasmic movement and
the translation of target transcripts13–16. Our previous data have
indicated that HuR associates with MyoD, myogenin and p21
transcripts only during the fusion step of myoblasts to form
myotubes5. This ﬁnding led to the conclusion that HuR promotes
myogenesis by stabilizing these mRNAs speciﬁcally at this step. In
the same study, however, we showed that depleting HuR from
proliferating myoblasts prevented their initial commitment to the
differentiation process. These observations indicated that HuR
promotes muscle ﬁbre formation by also regulating the
expression of target mRNAs during the early steps of myogenesis.
Recently, we discovered that HuR promotes myogenesis
through a novel regulatory mechanism involving its caspase-
mediated cleavage4. As muscle cells are engaged in the myogenic
process, a progressive accumulation of HuR in the cytosol is
triggered. In the cytoplasm, HuR is cleaved by caspase 3 at its
226th residue, an Asp (D), generating two cleavage products
(HuR-CPs: -CP1, 24 kDa and -CP2, 8 kDa). These HuR-CPs,
generated from B50% of cytoplasmic HuR, are required for
muscle ﬁbre formation4,8. Indeed, while wt-HuR can rescue
myogenesis in cells depleted of endogenous HuR, the non-
cleavable HuRD226A mutant failed to do so4,8. In addition, HuR-
CP1, by associating with import factor transportin 2, prevents
HuR nuclear import promoting its cytoplasmic accumulation.
While these data clearly establish that HuR-CP1 modulates
the cellular movement of HuR during myogenesis, the role of
HuR-CP2 remains unclear.
HuR is not the only RNA-binding protein involved in the post-
transcriptional regulation of promyogenic factors. The KH-type
splicing regulatory protein (KSRP) is known to associate, in
proliferating myoblasts, with the AREs of the myogenin and p21
mRNAs leading to their rapid decay3. By doing so, KSRP
participates in ensuring the proliferation of myoblasts and
prevents their premature commitment to the myogenic process.
KSRP promotes mRNA decay in muscle cells by recruiting
ribonucleases such as PARN and members of the exosome
complex (for example, EXOSC5) to ARE-containing mRNAs
such as myogenin and p21 (refs 3,17). It was also suggested that
when myoblasts become competent for differentiation, KSRP
releases myogenin and p21 mRNAs leading to their stabilization.
As a consequence, myoblasts enter myogenesis and fuse to form
myotubes3. Since at this same step HuR associates with and
stabilizes these ARE-bearing mRNAs5,7, we concluded that the
induction of myogenesis involves both KSRP and HuR that
modulate the expression of the same mRNAs in an opposite way
but at different myogenic steps.
Surprisingly, however, here we report that in undifferentiated
muscle cells, HuR and KSRP do not compete but rather
collaborate to downregulate the expression of a common target,
the Nucleophosmin (NPM, also known as B23) mRNA. HuR
forms a complex with KSRP that is recruited to a U-rich element
in the 30-UTR of NPM mRNA. The HuR/KSRP complex, in
collaboration with PARN and the exosome, then destabilizes the
NPM mRNA leading to a signiﬁcant reduction in NPM protein
levels. Our data also provide evidence supporting the idea that the
HuR/KSRP-mediated decrease of NPM expression represents one
of the main events that helps myoblasts commit to the myogenic
process.
Results
NPM is a HuR-mRNA target in undifferentiated muscle cells.
We ﬁrst identiﬁed the mRNAs that depend on HuR for their
expression in undifferentiated, C2C12 cells. Endogenous HuR
was depleted (siHuR) or not (siCtr) from these cells and total
RNA was then prepared and hybridized to mouse arrays con-
taining 17,000 probe sets of known and unknown expressed
sequence tags. Consistent with the fact that HuR acts as a stabi-
lizer for many of its mRNA targets10,12, we observed a signiﬁcant
decrease in the steady-state levels of 18 mRNAs in siHuR-treated
cells. Surprisingly, however, we found that 12 mRNAs are
signiﬁcantly upregulated in these cells (Supplementary Table 1).
While many of these transcripts do not have typical AREs and are
not known to modulate myogenesis, these observations suggested
that in muscle cells HuR, in addition to stabilizing some of its
target mRNAs, could also be involved in the destabilization
of other transcripts. Therefore, we investigated further this
unexpected possibility and assessed whether this HuR
destabilizing activity is part of its promyogenic function. To
this end, we chose to study, among these upregulated HuR-
mRNA targets, the NPM mRNA. NPM was identiﬁed as a target
of HuR in other cell systems18 and its downregulation has been
shown to be required for the differentiation of other cell
models19,20. Hence, moderating NPM expression in muscle cells
could be one of the early events through which HuR promotes
myogenesis.
First, we validated the results of our microarray data using
northern blot analysis. The knockdown of HuR in C2C12 cells
increased the level of NPMmRNA by twofold while, as previously
described5, it decreased the level of MyoD mRNA by 450%
(Fig. 1a). Knocking down HuR in these cells also increased NPM
protein levels, while myogenin protein levels were reduced
(Fig. 1b). Conversely, overexpressing GFP-HuR protein in
C2C12 cells signiﬁcantly decreased the levels of both NPM
mRNA and protein, compared with cells transfected with green
ﬂuorescent protein (GFP) only (Supplementary Fig. 1). Together,
these observations establish that in undifferentiated muscle cells,
HuR prevents the overexpression of NPM mRNA and protein.
HuR-mediated NPM mRNA destabilization promotes myo-
genesis. If downregulating NPM levels represent an important
event during the early steps of myogenesis, decreasing its
expression levels in C2C12 cells should promote their ability to
enter this process. To investigate this possibility, we assessed
NPM mRNA and protein levels during muscle cell differentiation.
We observed that, although, as expected21, MyoD mRNA levels
increased during this process, the abundance of the NPM mRNA
and protein signiﬁcantly decreased as soon as myogenesis was
initiated (Fig. 2a–c). To determine whether decreasing NPM
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expression is required for the initiation of myogenesis, we tested
the impact that NPM knockdown (Fig. 2d) could have on the
ability of C2C12 cells, expressing or not HuR, to enter this
process. We observed that the depletion of endogenous NPM by
small interfering RNA (siRNA) not only triggered the formation
of more and larger muscle ﬁbres when compared with
siCtr-treated cells, but also re-established myogenesis in HuR-
knockdown C2C12 cells (Fig. 2d–h and Supplementary Fig. 2).
These observations, together with the fact that overexpressing
GFP-NPM prevented myogenesis (Supplementary Fig. 3),
clearly demonstrate that one way by which HuR promotes the
early steps of muscle ﬁbre formation is by downregulating NPM
expression.
We have previously shown that HuR is cleaved during muscle
cell differentiation into two cleavage products HuR-CP1 (24 kDa)
and HuR-CP2 (8 kDa). Our data also indicated that HuR cleavage
is a key regulatory event required for proper muscle ﬁbre
formation4. Since our data (Fig. 2c) have shown that the cleavage
of HuR during myogenesis correlates with a decrease in NPM
expression, we decided to investigate the effect of HuR-CPs on
NPM expression in muscle cells. As expected, we observed that in
muscle cells depleted of endogenous HuR, the wild-type (wt-
HuR) but not the non-cleavable isoform of HuR (HuRD226A)
was able to re-establish myogenesis as well as the downregulation
of the steady-state level of the NPM mRNA. Surprisingly,
however, HuR-CP2 but not HuR-CP1 was also able to re-
establish, in these cells, the downregulation of NPM mRNA levels
and myogenesis similarly to wt-HuR (Fig. 2i–l). While these
results suggest a correlation between HuR cleavage and the HuR-
mediated downregulation of the NPM transcript, they clearly
indicate that the C terminus of HuR could play an important role
in this effect.
To identify the mechanisms responsible for the decreased
expression of NPM mRNA during myogenesis (Fig. 2a), we ﬁrst
performed a nuclear run-on assay22 to assess whether this
decrease is due to a change in transcription. Since we did not
observe any change in the transcription rate during myogenesis
(Supplementary Fig. 4), we concluded that the HuR-mediated
downregulation of NPM mRNA expression is likely to occur at
the level of mRNA stability. Indeed, a pulse-chase experiment23
using the RNA polymerase II inhibitor actinomycin D (ActD)
showed that depleting HuR in C2C12 cells signiﬁcantly increased,
fromB5 to49 h, the half-life of the NPM mRNA (Fig. 3a,b). Of
note, treatment of cells with ActD did not affect their viability
(Supplementary Fig. 5). These results, together with the fact that
HuR does not affect the localization or the translation of the NPM
mRNA (Fig. 3c,d), indicate that HuR promotes the formation of
muscle ﬁbres by destabilizing the NPM mRNA.
HuR destabilizes NPM mRNA via U-rich elements in the 30-UTR.
HuR is known to regulate its mRNA targets by interacting with
AU-/U-rich elements in their 30-UTRs9,24. Therefore, to deﬁne the
molecular mechanism by which HuR destabilizes the NPM mRNA,
we ﬁrst assessed whether HuR and NPMmRNA associate in muscle
cells. Immunoprecipitation (IP) (Fig. 4a) followed by reverse
transcription PCR (RT-PCR; upper panel) or RT-quantitative PCR
(RT-qPCR; lower panel) analyses23,25 showed that HuR and the
NPM mRNA coexist in the same complex in muscle cells. To
determine whether this association is direct or indirect, we
performed RNA electromobility shift assays (REMSAs)23 using
recombinant glutathione S-transferase (GST) or GST-HuR proteins
and radiolabelled RNA probes corresponding to the entire 50- or 30-
UTRs of NPM mRNA (Fig. 4b). We observed that GST-HuR forms
a complex only with the 30 but not the 50-UTR of NPM mRNA
(Fig. 4c). To further deﬁne the binding site(s) of HuR, we divided the
NPM 30-UTR into two probes P1 and P2 (Fig. 4b) and observed a
strong association of GST-HuR with only the P1 probe (Fig. 4d).
Using surface plasmon resonance analysis, we conﬁrmed these
associations and showed that GST-HuR is bound to the NPM-30-
UTR and P1 probe with higher afﬁnity (dissociation constants (KD)
of 86 10 9 and 132 10 9M, respectively) than the P2 probe
(KD¼ 324 10 9M) (Fig. 4e). In addition, further subdivision of
P1 and 2 probes into three smaller regions, P1/2-1, -2 and -3,
showed that HuR only binds to the P1-1 region of NPM-30-UTR
(Fig. 4f and Supplementary Fig. 6a,b). Analysis of the secondary
structure of the P1-1 region using the mfold prediction software for
mRNA folding26 indicated the existence of two U-rich elements (E1
and E2) similar to HuR cis-binding motifs previously identiﬁed in
other mRNA targets11,23,26 (Supplementary Fig. 6c). To determine
whether E1 and/or E2 elements mediate the binding of HuR to the
NPM 30-UTR, we mutated each one of their uracils (Us; shown as
Ts) as well as those of the element separating E1 and E2 to cytosine
(C) (Fig. 4g) and performed REMSA experiments as described
above. Since mutating each site separately (P1-1-mut1 or -mut2),
but not those of the hinge element (P1-1-mut3), equally disrupted
the P1-1/HuR complex (Fig. 4h,i), we concluded that the E1 and E2
elements together constitute the minimum U-rich element required
for the direct binding of HuR to the NPM-30-UTR.
Next, we tested whether these U-rich elements are involved in
the HuR-mediated destabilization of the NPM mRNA in muscle
cells. We generated reporter complementary DNA (cDNA)
plasmids expressing the Renilla luciferase (Rluc) in which
we inserted, at the 30 end, either the wild-type NPM 30-UTR
(Rluc-NPM-30) or the NPM 30-UTR mutant 1 (Rluc-NPM-30-
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Figure 1 | HuR regulates NPM expression in muscle cells. Exponentially
growing C2C12 myoblasts were transfected with the HuR or control (Ctr)
siRNAs. (a) RNA was prepared 48 h after transfection with HuR or Ctr
siRNAs. Northern blot was performed using radiolabelled probes against
NPM, MyoD, HuR mRNAs and 18S (loading control). The band intensities of
NPM, MyoD mRNAs and 18S were determined using ImageQuant Software.
The NPM and MyoD mRNA levels were normalized on 18S rRNA level.
(b) Forty-eight hours after transfection with HuR or Ctr siRNAs, whole-cell
extracts were prepared and western blot was performed using antibodies
against NPM, HuR, myogenin and a-tubulin (loading control). ImageQuant
was used to determine the NPM level, normalized on a-tubulin level.
In the histograms, the siRNA HuR condition was plotted relative to the
siRNA Ctr condition±s.e.m. of three independent experiments *Po0.01,
**Po0.001 (t-test).
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Figure 2 | Reducing NPM level is required for the commitment of muscle cells into the myogenic process. (a,b) Total RNA was isolated from
exponentially growing (Exp) or conﬂuent C2C12 myoblasts (day 0) and during the differentiation process (days 2,3). (a) NPM and (b) MyoD mRNA levels,
determined by RT-qPCR, were standardized against GAPDH mRNA and expressed relative to the exponential condition. Values were plotted±s.e.m. of
three independent experiments. (c) Total cell extracts were prepared from growing (Exp) as well as differentiating C2C12 myoblasts (days 1–5) and used for
western blot with antibodies against NPM, HuR or a-tubulin (loading control). The NPM protein level was determined using the Imagequant software,
standardized against tubulin levels and plotted relative to the exponential condition±s.e.m. of three independent experiments. (d–h) Knockdown of HuR,
NPM and NPMþHuR was performed in C2C12 cells and differentiation was induced 48 h post treatment with siRNAs. (d) Total cell lysates were prepared
48 h post transfection and used for western blot with antibodies against NPM, HuR and a-tubulin. (e) Phase contrast pictures showing the differentiation
status at d0 and d3. Scale bar, 50mm. (f) Immunoﬂuorescence experiments were performed using the anti-My-HC antibody and DAPI staining. Images of a
single representative ﬁeld were shown. Scale bar, 10mm. (g) The fusion index (calculated from three independent experiments) was determined for muscle
ﬁbres shown in f. (h) Total cell extracts were prepared from the cells described above and used for western blot analysis using antibodies against myoglobin
and a-tubulin. (i–l) C2C12 cells depleted or not of HuR were treated twice (see Methods) with 50 nM AP-GST, -HuR-GST, -CP1-GST, -CP2-GST or -
HuRD226A-GST and 24 h after the second treatment with these chimera they were induced for differentiation. (i) Immunoﬂuorescent images and
(j) fusion index of ﬁbres ﬁxed on day 3 of differentiation process. Scale bar, 10mm. (k,l) NPM (k) and MyoD (l) mRNA levels in conﬂuent myoblasts treated
as described above. mRNA levels were plotted relative to the GST- and siCtr-treated conditions±s.e.m. of three independent experiments. For histograms
in g,k, *Po0.01, **Po0.001 (t-test).
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mut1, deﬁcient in its ability to bind HuR) (Figs 4h and 5a). An IP/
RT-qPCR experiment showed that the association between HuR
and the Rluc-NPM-30 mRNA is signiﬁcantly higher than its
association with the control reporters Rluc or Rluc-NPM-30-mut1
(Fig. 5b,c). We next assessed the impact of depleting endogenous
HuR on the expression of the Rluc-NPM-30 mRNA. siCtr- or
siHuR-treated C2C12 cells were transfected with the Rluc, Rluc-
NPM-30 or Rluc-NPM-30-mut1 plasmids (Supplementary Fig. 7a)
and the steady-state levels of these mRNAs were determined by
RT-qPCR analysis. While we observed a 3.5-fold increase in the
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level of the Rluc-NPM-30 mRNA in cells depleted of HuR, but not
in those treated with siCtr, the levels of Rluc-NPM-30-mut1
remained high in both cell types (Fig. 5d). On the other hand,
overexpressing GFP-HuR in C2C12 cells decreased the level of
the Rluc-NPM-30 mRNA by 465% but had no signiﬁcant effect
on the levels of Rluc or Rluc-NPM-30-mut1 mRNAs (Fig. 5e,
Supplementary Fig. 7c). The effect of knocking down or
overexpressing HuR on luciferase activity (which is proportional
to Rluc protein levels) was similar to those seen for the mRNA
levels (Supplementary Fig. 7b,d). Next, we investigated the
functional relevance of these HuR-binding sites on NPM mRNA
stability. We performed ActD pulse-chase experiments on C2C12
cells expressing the various Rluc reporters described above and
treated or not with 50 nM of recombinant HuR conjugated to the
cell-permeable peptide Antenapedia (AP)14 (Fig. 5f). We
observed that the half-life of the Rluc-NPM-30 mRNA was
signiﬁcantly reduced (o2 h) only in cells treated with AP-HuR-
GST but not in those treated with AP-GST (46 h). However, the
Rluc-NPM-30-mut1 mRNA remained stable under all treatments
(half-life 46 h). While these results clearly demonstrate that an
intact HuR-binding site is required for HuR-induced
destabilization of the NPM mRNA, it does not provide any
indication on their relevance during myogenesis. To address this
question, we generated GFP-conjugated full-length wild-type
(GFP-NPM-30) or mutated (GFP-NPM-30-mut1) isoforms of
NPM (Fig. 5g). These NPM isoforms were then overexpressed in
C2C12 cells and 48 h later these cells were induced for
differentiation for 3 days. Our experiments showed that
overexpressing GFP-NPM-30 reduced the efﬁciency of muscle
ﬁbre formation by B50% when compared with GFP alone
(Fig. 5h–j). Interestingly, the overexpression of the GFP-NPM-30-
mut1 isoform, which does not bind HuR, provided a much higher
inhibition of myogenesis efﬁciency than GFP-NPM-30 (470%).
Together, these results show that the recruitment of HuR to the
E1 and E2 U-rich elements of NPM 30-UTR is required for NPM
downregulation and the promotion of myogenesis.
HuR destabilizes the NPM mRNA in a KSRP-dependent
manner. It has been shown that during myogenesis, transcripts
such as myogenin and p21 but not MyoD are destabilized by
KSRP in proliferating myoblasts3. However, at later stages (fusion
step), these mRNAs are stabilized by HuR, leading to an increase
in their expression levels and to the promotion of myotube
formation5,7. Therefore, since KSRP and HuR target common
transcripts in muscle cells3,5,7 and our observation showed that
depleting the expression of either of these two proteins in C2C12
cells equally prevented myogenesis (Supplementary Fig. 8), we
tested whether KSRP could be implicated in the HuR-mediated
destabilization of the NPM mRNA in proliferating C2C12 cells.
We ﬁrst determined the effect KSRP depletion could have on the
expression level of the NPMmRNA and protein. We showed that,
similarly to HuR depletion, the knockdown of KSRP signiﬁcantly
increased the expression levels of NPM mRNA (42-fold) and
protein (41.5-fold) (Fig. 6a,b). In addition, ActD pulse-chase
experiments indicated that the knocking down KSRP increased
the half-life of NPM mRNA to a similar extent than HuR
(compare Fig. 3b with Fig. 6c). However, as expected3, KSRP
knockdown had no effect on the stability of the MyoD mRNA,
while it increased the half-life of p21 mRNA fromB3.6 to 46 h
(Fig. 6c). Altogether, these data show that both HuR and KSRP
decrease the expression level of the NPM protein by shortening
the half-life of the NPM mRNA. Surprisingly, we additionally
observed that overexpressing KSRP alone in C2C12 cells, unlike
HuR, does not affect NPM mRNA or protein levels (Fig. 6d,e)
despite promoting the decreased expression of p21. Since
knocking down KSRP by 490% prevented the HuR-mediated
decrease of the NPM mRNA and protein (Fig. 6f–h), we
concluded that, although KSRP alone is not able to destabilize
NPM mRNA, KSRP is required for the HuR-mediated
downregulation of NPM level in muscle cells.
To gain insight into the molecular mechanisms by which HuR
and KSRP affect the fate of NPM mRNA in muscle cells, we ﬁrst
determined whether KSRP also associates with this transcript. IP
experiments using the anti-KSRP antibody17 followed by RT–PCR
and -qPCR analyses showed that KSRP binds to the NPM
mRNA similarly to HuR (Figs 4a and 7a). REMSA using total
extracts prepared from C2C12 cells that were incubated with
radiolabelled NPM-30-UTR or the P1 or P2 probes (Fig. 4b) and
with the anti-KSRP antibody showed that, similarly to HuR
(Fig. 4), KSRP associates with the 30-UTR of NPM through the P1
but not the P2 region (Fig. 7b). To determine the KSRP-binding
site(s) in the NPM 30-UTR, we incubated the recombinant KSRP
with intact or mutated radiolabelled P1 probes and performed the
same REMSA experiments described in Fig. 4. KSRP formed
complexes with P1-1 and P1-1-mut2 but not with P1-1-mut1
(mut-E1) probes (Fig. 7c). In addition, IP experiments with anti-
KSRP antibody were performed on cells expressing the Rluc
reporters described in Fig. 5a. We observed that, while KSRP
associated with the Rluc-NPM-30 mRNA and Rluc-NPM-30-mut2,
it failed to interact with the Rluc-NPM-30-mut1 message (Fig. 7d,e
and Supplementary Fig. 9). Therefore, together these results
show that KSRP directly associates with the NPM mRNA
through the E1 element that is also one of the sites that mediates
HuR binding.
Next, we investigated whether HuR and KSRP can form a
complex. IP experiments on cell extracts treated or not with
100 mgml 1 RNAse A indicated that HuR and KSRP associate
in C2C12 cells in an RNA-independent manner (Fig. 7f,g).
Figure 4 | HuR binds to the NPM mRNA via two U-rich sequences within the 30-UTR. (a) IP experiments were performed using the monoclonal
HuR antibody (3A2), or IgG as a control, on total cell lysates from C2C12 cells. RNA was isolated from the immunoprecipitate, and RT-PCR or RT-qPCR was
performed using primers speciﬁc for NPM and RPL32mRNAs. The agarose gel (upper panel) shown is representative of three independent experiments. For
RT-qPCR (lower panel), NPM mRNA levels were standardized against RPL32 mRNA levels. The normalized NPM mRNA levels were plotted relatively to the
IgG IP condition±s.e.m. of three independent experiments. **Po0.001 (t-test). (b) Schematic representation of the NPM mRNA sequence. The probes
covering the NPM 30-UTR (P1, P2, P1-1 to P1-3) used to generate radiolabelled RNA probes for REMSAs are indicated (black lanes). (c,d,f,h,i) Gel-shift
binding assays were performed by incubating 500ng of puriﬁed GSTor GST-HuR protein with the radiolabelled cRNA (c) 30-UTR and 50-UTR, (d) P1 and P2,
(f) P1-1 to P1-3, (h) P1-1, P1-1-mut1 and P1-1-mut2 and (i) P1-1 and P1-1-mut3 probes. These gels are representative of three independent experiments.
*shown in panels 4c, f and h indicate the location of shifted complex. (e) BIACORE, a surface plasmon resonance-based biosensor technology, was used for
a kinetic binding study between GST-HuR and NPM 30-UTR, P1 or P2 probes. GST-HuR was captured on a Series S CM5 chip and increased concentrations
of NPM cRNA probes, as indicated, were injected over the surface. Injections were performed for 150 s to measure association, followed by a 400 s ﬂow of
running buffer to assess dissociation. The association/dissociation ratio of GST-HuR to NPM 30-UTR is shown in the sensorgram (top left panel). The
binding afﬁnity (KD) of GST-HuR to NPM 3
0-UTR (top right panel), P1 or P2 (bottom panels) cRNA probes is also shown. (g) Nucleotide sequence of probe
P1-1 showing the thymidine (T) residues that were mutated to cytidine (C) residues (identiﬁed by asterisks) to generate the P1-1-mut1, P1-1-mut2 and
P1-1-mut3. The sequences highlighted by the dashed boxes as E1 and E2 are the single-strand AU-rich sequences identiﬁed using mfold software.
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Figure 5 | An intact P1-1 element is required for HuR-mediated regulation of NPM expression. (a) Schematic diagram of the Renilla luciferase reporters
used in the experiments described in a–f. (b,c) Exponentially growing C2C12 cells were transfected with plasmids expressing Rluc, Rluc-NPM-30 or Rluc-NPM-30-
mut1. Total extracts from these cells were prepared 24h after transfection and used for IP using the anti-HuR antibody (3A2) or IgG as a control. (b) Western blot
analysis with the anti-HuR antibody was performed using these IP samples. (c) Rluc mRNA associated with the immunoprecipiated HuR was determined by RT-
qPCR. The relative Rluc RNA levels from Rluc-NPM-30 and Rluc-NPM-30-mut1 were plotted relatively to the Rluc RNA reporter±s.e.m. of three independent
experiments. (d,e) The expression levels of these Rluc RNA reporters were also determined by RT-qPCR in C2C12 cells depleted or not of HuR (d) or
overexpressing GFP or GFP-HuR (e). The expression levels of the Rluc mRNAs were normalized over total Rluc DNA transfected as described59 and then
standardized against GAPDHmRNA level±s.e.m. of three independent experiments **Po0.001; NS, non signiﬁcant (t-test). (f) C2C12 cells were transfected with
the Rluc reporter RNA described above in the presence of AP-GSTor AP-HuR-GSTproteins. The stability of these reporter Rluc mRNAs was determined by AcD
pulse-chase experiments. The percentages shown were plotted±s.e.m of three independent experiments. (g) Schematic diagram of GFP or the GFP-conjugated
full-length NPM isoforms: WT NPM (GFP-NPM-30) and the NPM 30-UTR with the ﬁrst AU-rich sequence mutated (GFP-NPM-30-mut1). The coding region of
NPM is shown as NPM CDR. (h–j) C2C12 cells expressing these isoforms or the GFP-HuR protein were ﬁxed on day 3 of muscle cell differentiation. (h) Phase
contrast images of the myotubes described above. (i) Immunoﬂuorescence (using the anti-My-HC antibody) images of these myotubes. (j) Fusion index±s.e.m
of three independent experiments, **Po0.001, ***Po0.0001 (t-test). Images of a single representative ﬁeld are shown. Scale bar, 50mm (h) and 10mm (i).
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cells±s.e.m. of three independent experiments. In the histograms presented in a,b,e,h, *Po0.01, **Po0.001, ***Po0.0001 (t-test).
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However, this RNA-independent interaction between HuR and
KSRP was not seen using a lower dose of RNAse A
(12.5mgml 1). Moreover, GST pull-down experiments, using
recombinant His-KSRP and GST-HuR, further conﬁrmed this
direct interaction (Fig. 7h). We then assessed whether the
association between the NPM mRNA and HuR or KSRP requires
an intact HuR/KSRP complex. IP/RT-qPCR experiments showed
that depleting HuR from C2C12 cells signiﬁcantly decreased
(440%) the amount of NPM mRNA that binds to KSRP (Fig. 7i).
Similarly, although knocking down KSRP in C2C12 cells did not
affect the binding of HuR to the myogenin and p21 mRNAs
(Supplementary Fig. 10), it decreased its association with the
NPM mRNA (Fig. 7j). Taken together, these data suggest that in
muscle cells the HuR/KSRP complex assembles in an RNA-
independent manner and is recruited to the P1-1 element, thus
promoting the rapid destabilization of the NPM mRNA.
To gain insight into the mechanism by which HuR executes
these functions, we ﬁrst determined the HuR domain responsible
for this activity. We generated plasmids expressing GFP-tagged
wild-type HuR or various deletion mutants of HuR (Fig. 8a). Each
one of these isoforms was then expressed in C2C12 cells that were
subsequently used for IP experiments with the anti-KSRP
antibody. Western blot analysis with the anti-GFP antibody has
shown that, similarly to wt-HuR, polypeptides harbouring the
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using antibodies against GFP. (c) RT-qPCR analysis of total RNA prepared from these cells was performed using speciﬁc primers for NPM, MyoD and
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RRM3 motif (GFP-HNS-RRM3 and GFP-RRM3), but not those
harbouring RRM1-2 or HuR nucleocytoplasmic shuttling (HNS)
alone, were able to associate with KSRP (Fig. 8b) and promote a
signiﬁcant decrease in NPM mRNA level (Fig. 8c). In addition, an
IP/RT-qPCR experiment on cells expressing GFP-HuR, -RRM1-2
or -RRM3 indicated that, while RRM1-2 did not show a strong
association with the NPM mRNA, RRM3 associated more with
NPM message than wt-HuR (Fig. 8d,e). Since, during myogenesis,
cytoplasmic HuR undergoes caspase-mediated cleavage generat-
ing HuR-CP1 (24 kDa, RRM1-RRM2-DHNS1) and HuR-CP2
(8 kDa, DHNS2-RRM3)4 (Fig. 2C and Supplementary Fig. 11a),
we next veriﬁed the effect of these CPs on NPM expression. Our
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data conﬁrmed that HuR-CP2, which harbours the RRM3 motif,
but not HuR-CP1, associated with KSRP and the NPM mRNA
and was also able to form a complex with the HuR/KSRP-binding
element in the NPM 30-UTR (the P1-1 probe) (Supplementary
Fig. 11b–g). In addition, similarly to GFP-RRM3 (Fig. 8c), we
observed that the overexpression of HuR-CP2 promoted a
signiﬁcant decrease in NPM mRNA steady-state levels in a
KSRP dependent manner (Supplementary Fig. 11h,i). Together,
these results strongly indicate that the RRM3 motif
of HuR plays a key role in mediating the formation of the
HuR/KSRP in differentiating muscle cells.
Since KSRP has been shown to promote mRNA decay by
recruiting the ribonuclease PARN and components of the
exosome such as EXOSC5 (refs 3,17), we investigated whether
enzymes could play a role in the HuR/KSRP-mediated
destabilization of NPM mRNA. Our IP experiments showed
that HuR associates with both PARN and EXOSC5 in an RNA-
independent manner (Fig. 9a and Supplementary Fig. 12).
Interestingly, although both PARN and EXOSC5 interact with
the NPM mRNA in C2C12 cells, this association is lost in HuR-
or KSRP-depleted cells (Fig. 9b). To assess whether PARN and/or
EXOSC5 play a role in the HuR/KSRP-mediated effect on NPM
expression, we expressed GFP-HuR or GFP-HuR-CP2 in C2C12
cells depleted or not of these two ribonucleases (Fig. 9c), and the
expression level of the NPM mRNA was determined using RT-
qPCR. Our data showed that, while knocking down PARN
(Fig. 9d) or EXOSC5 (Fig. 9e) in C2C12 cells increased the
expression of the NPM mRNA, the absence of these ribonucleases
prevented the HuR- or HuR-CP2-mediated NPM mRNA decay
(Fig. 9f). The fact that the depletion of XRN1 (a 50–30
exoribonuclease component of the decapping complex)27
did not have a major effect on NPM mRNA expression
(Supplementary Fig. 13) suggests that only ribonucleases that
are recruited by KSRP such as PARN and EXOSC5 take part in
this destabilization activity. Interestingly, we also demonstrate
that knocking down PARN and EXOSC5 totally prevented
C2C12 cells from entering the differentiation process (Fig. 9g–i)
and the depletion of NPM in these cells partially re-established
their myogenic potential (Supplementary Fig. 14). Of note, the
weak rescue of myogenesis in cells depleted of both EXOSC5 and
NPM suggests that EXOSC5 targets other messages in muscle
cells. Together, our data indicate that during early myogenesis the
formation of the HuR/KSRP complex leads to the recruitment
of ribonucleases such as PARN and EXOSC5, which in turn de-
stabilize the NPM mRNA, thus promoting muscle ﬁbre formation.
Discussion
In this work, we delineate the molecular mechanisms by which
muscle cells downregulate NPM expression and show that this
event represents a key regulatory step required for their
commitment to myogenesis. Although previous studies have
indicated that lowering the expression of NPM is required for the
differentiation of a variety of cells such as HL60 and K562 (refs
19,20), the molecular mechanism and the players behind this
reduction remained elusive. Here we show that the decrease in
NPM expression involves the destabilization of its mRNA via a
mechanism mediated by the RNA-binding protein HuR. This
observation was unexpected since HuR has been previously
shown to stabilize the NPM mRNA in intestinal cells undergoing
stress18. In undifferentiated muscle cells, the depletion of
endogenous HuR results in the stabilization of the NPM mRNA
and its increased expression, while HuR overexpression elicits the
opposite effects. This mRNA destabilization activity of HuR
involves its association, via the HuR-RRM3 motif, with KSRP and
the ribonucleases PARN and EXOSC5 (ref. 17). Together, our
data support a model whereby in response to a myogenic signal,
HuR forms a complex with KSRP, PARN and the exosome, which
in turn is recruited to a U-rich element in the 30-UTR, leading to
the destabilization of the NPM mRNA and the promotion of the
early steps of myogenesis.
Although a NPM overexpression was previously linked to
the inhibition of the differentiation of human promyelocytic
leukaemia HL60 cells and megakaryocytic K562 cells19,20, our
work provides the ﬁrst demonstration that NPM is implicated in
muscle ﬁbre formation. NPM is highly expressed in a variety of
cell lines and tissues and has been involved in many cellular
processes such as cell proliferation and stress response28,29. In
fact, manipulating the abundance of NPM has a dramatic effect
on cell fate and on embryogenesis. Npm / mice do not
complete their embryonic development and die between
embryonic days E11.5 and E16.5 due to a severe anaemia
caused by a defect in primitive hematopoiesis30. On the other
hand, a high expression level of NPM is involved in cell
transformation and tumour progression29,31–33. NPM levels
signiﬁcantly decrease in response to a variety of stimuli, among
them those known to trigger cell cycle arrest and cell
differentiation19,20,29. These data and the fact that NPM and
HuR are both essential for the development of numerous cell lines
and tissues12,28,29,34–36 highlight the importance of delineating
the mechanism(s) by which HuR downregulates NPM expression.
Previously, others and we have demonstrated that HuR plays a
prominent role during muscle cell differentiation by increasing
the stability of promyogenic mRNAs at the later stages of this
process5,7. Here we show that HuR is also involved in the early
stages of myogenesis by degrading the NPM mRNA in a KSRP-
dependent manner. Since previous reports have indicated that
during myogenesis HuR and KSRP affect the half-lives of
the same promyogenic transcripts, but in opposite ways, their
Figure 9 | The HuR/KSRP-mediated decay activity requires PARN and EXOSC5 to destabilize NPM mRNA and promote muscle ﬁbre formation.
(a) IP experiments using the anti-PARN antibody were performed on total cell extracts prepared from proliferating C2C12 cells treated or not with RNase A.
The precipitates were used for western blot analysis with anti-PARN and -HuR antibodies. The blots shown are representative of two independent
experiments. (b) IP coupled to RT-qPCR experiments was performed using the PARN or the EXOSC5 antibodies on total extract from C2C12 cells treated
with siHuR or siKSRP. The NPM mRNA in the immunoprecipitate was standardized and normalized as described in Fig. 7i,j. The PARN- or EXOSC5-
associated NPM mRNA levels in siHuR- or siKSRP-treated C2C12 cells were plotted relative to siCtr conditions±s.e.m. of three independent experiments,
*Po0.01 (t-test). (c–f) GFP, -HuR and -CP2 proteins were expressed in C2C12 cells treated or not with siRNA-PARN or -EXOSC5. Twenty-four hours later,
protein extracts and total RNA were prepared. (c) Western blot analysis was performed using antibodies against GFP and a-tubulin (loading control).
(d–f) RT-qPCR analysis was performed using primers speciﬁc for GAPDH as well as PARN (d), EXOSC5 (e) and NPM (f) mRNAs. The levels of PARN,
EXOSC5 and NPM mRNAs were normalized against GAPDH mRNA level and were plotted relatively to the siRNA Ctr-treated and GFP-transfected
cells±s.e.m. of three independent experiments, *Po0.01 (t-test). (g–j) Conﬂuent C2C12 cells depleted of PARN or EXOSC5 were induced for
differentiation for up to 4 days. (g) Phase contrast pictures showing the differentiation status of these cells at day (d) d0 (a–c), d2 (d–f) and d3 (g–i).
Scale bar, 50mm. (h) These cells, on day 4 of muscle cell differentiation, were also ﬁxed and used for IF with anti-myoglobin antibody and DAPI
staining. Images of a single representative ﬁeld were shown. Scale bar, 10 mm. (i) The fusion index was determined as described in Methods. (j) Total
extracts from these cells were prepared and used for western blot analysis with antibodies against My-HC, NPM and a-tubulin (loading control).
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collaboration to degrade a common target mRNA in
undifferentiated muscle cells was unexpected. Indeed, it has
been shown that KSRP plays a key role in maintaining low levels
of p21 and myogenin mRNAs in undifferentiated muscle cells by
promoting their rapid decay3. The fact that HuR does not
associate with these mRNAs in these cells5 could explain why
these transcripts became available to KSRP and the KSRP-
associated decay machinery. However, during the step where
muscle cells fuse to form myotubes, p38MAPK phosphorylates
KSRP leading to the release of p21 and myogenin mRNAs from
this decay machinery3. These ﬁndings, together with the data
outlined in this manuscript, conﬁrm the importance of HuR
during muscle ﬁbre formation and indicate that the functional
consequences and the binding speciﬁcity of HuR to its target
mRNA could change from one myogenic step to another
depending on the nature of its protein ligand.
It is not surprising that HuR exerts different/opposite functions
on its target transcripts. Numerous reports have indicated that
depending on extra- or intracellular signals and/or the trans- or
the cis-binding partners, HuR either activates or represses the
turnover or translation of its mRNA targets10,16,37,38. Indeed, the
Steitz laboratory has shown that HuR mediates the decay of the
viral small nuclear RNA Herpesvirus saimiri U RNA 1 (HSUR 1)
in an ARE-dependent manner39,40. Recently, HuR has been
associated with the destabilization of the p16 mRNA both in
HeLa and in IDH4 cells38. HuR participates in the decay of this
message by forming a complex with AUF1 and Argonaute, two
well-known mRNA decay factors38,41–43. Our data uncover a
novel mechanism by which HuR mediates the decay of its mRNA
target leading to muscle ﬁbre formation. This mRNA decay-
promoting activity of HuR depends on its association with KSRP,
a factor known to promote the decay of ARE-containing
mRNAs17,44. Interestingly, besides a difference in the way they
form, the HuR/AUF1 and HuR/KSRP complexes also show a
difference in their functional outcome. While in muscle cells
HuR/KSRP assemble in a RNA-independent manner before their
recruitment to the same U-rich element in the NPM 30-UTR, the
formation of the HuR/AUF1 complex in HeLa cells is RNA
dependent and occurs via the binding of each one of these two
proteins with a different element in the p16 30-UTR38. Likewise,
unlike the HuR/AUF1 complex that promotes the proliferation of
HeLa and IDH4 cells38, the HuR/KSRP complex triggers the
differentiation of muscle cells, an event linked to a cell cycle
withdrawal21.
Besides the association with different protein ligands, we still
do not know whether other processes such as post-translational
modiﬁcations are also involved in the functional switch of HuR
during myogenesis. It has been shown that phosphorylation
on various serine residues could impact the association of
HuR with some of its target mRNAs such as p21 (refs 45–47).
While the implication of phosphorylation in HuR-mediated
effects in muscle cells is still elusive, we recently showed that
caspase-mediated cleavage plays a key role in modulating the
promyogenic function of HuR in refs 4 and 8. Although our data
indicated that HuR-CP1 promotes the cytoplasmic accumulation
of HuR during the myoblast-to-myotube fusion4, the function of
HuR-CP2 remained unclear. Here we demonstrate that HuR-CP2
associates with KSRP and is sufﬁcient to downregulate the
expression of NPM mRNA in muscle cells (Supplementary
Fig. 11). Interestingly, we also show that, unlike the non-cleavable
isoform of HuR (HuRD226A), HuR-CP2 can re-establish the
myogenic potential of C2C12 cells depleted of endogenous HuR
(Fig. 2i–l). While additional experiments are needed to conﬁrm
the role of this cleavage product in the promyogenic function of
HuR, these observations raise the possibility of its implication in
maintaining a low expression of levels of NPM during
myogenesis. While these and likely other modiﬁcations
modulate HuR function in muscle cells, the data described
above establish that HuR, through its ability to promote the decay
of target mRNAs, acquires more ﬂexibility to use different ways to
impact important processes such as muscle ﬁbre formation.
Therefore, since a change in HuR function and associated
partners has been linked to chronic and deadly diseases such as
cancer and muscle wasting48–50, delineating the molecular
mechanisms behind the HuR-mediated mRNA decay activity
could identify novel targets that help design effective strategies to
treat these patients.
Methods
Plasmid construction. The pYX-Asc plasmid containing the full-length mouse
NPM cDNA (Accession Number: BC054755) was purchased from Open Biosys-
tems (Catalogue Number: MMM1013-9497870). To generate the GFP-NPM
plasmid, full-length mouse NPM was ampliﬁed by PCR using the pYX-Asc plasmid
as template and the following primers: forward 50-GGCAAGCTTCGTCTGTTCT
GTGGAACAGGA-30 and reverse 50-CGGGATCCGGGAAAGTTCTCACTTTGC
ATT-30 . The pAcGFP1-C1 (Clontech) and the PCR products were digested by
HindIII and BamHI restriction enzymes (NE Biolabs). To generate the pRL-SV40-
NPM plasmid, the full-length 30-UTR of mouse NPM was ampliﬁed by PCR using
the pYX-Asc plasmid as template and the following primers: forward 50-GCTCTA
GAGAAAAGGGTTTAAACAGTTTGA-30 and reverse 50-CCGGCGGCCGCAC
TTTATTAAAATACTGAGTTTATT-30 . The pRL-SV40 vector (Promega) and the
PCR products were digested by XbaI and NotI restriction enzymes (NE Biolabs).
PCR inserts were ligated into the plasmids using the T4 DNA ligase (NE Biolabs)
according to the manufacturer’s instructions. pRL-SV40-NPMmut1 and mut2
plasmids were generated by Norclone Biotech Laboratories, Kingstone, ON,
Canada (as described in text). The GFP and GFP-HuR plasmids were generated
and used as described in ref. 51.
Cell culture and transfection. C2C12 muscle cells (ATCC, Manassas, VA, USA)
were grown in a media containing 20% fetal bovine serum (Invitrogen) in DMEM
(Dulbecco’s modiﬁed Eagle medium from Invitrogen). To induce muscle cell dif-
ferentiation, cells were switched to a media containing DMEM, 2% horse serum,
penicillin/streptomycin antibiotics (Invitrogen) and 50mM HEPES, pH 7.4
(Invitrogen), when their conﬂuency reached 100%5,6.
For the generation of stable cell lines, C2C12 cells were transfected with GFP,
GFP-HuR and GFP-NPM plasmids, and 24 h post-transfection G418 (1mgml 1;
Sigma-Aldrich) was added to the media. The stable cell lines were selected with
G418 for 2 weeks and then sorted by ﬂow cytometry (ﬂuorescence-activated cell
sorting) to select clones with equal expression levels. Transfections with siRNAs
speciﬁc for HuR were performed using jetPEI (Polyplus Transfection) according to
the manufacturer’s instructions. For DNA plasmid transfections, C2C12 cells at
70% conﬂuency were transfected into six-well plates with 1.5 mg of plasmid
DNA using Lipofectamine and Plus reagents (Invitrogen) according to the
manufacturer’s instructions. Cells were subsequently incubated at 37 C for 24 h
before collecting and analysis.
siRNA. siRNA oligonucleotides against HuR (50-AAGCCUGUUCAGCAGCAUU
GG-30 (ref. 5)), NPM (50-CAUCAACACCGAGAUCAAAdTdT-30) (Dharmacon,
USA), KSRP (50-GGACAGUUUCACGACAACGdTdT-30 (ref. 3)) and the siRNA
Ctr (50-AAGCCAAUUCAUCAGCAAUGG-30) ref. 5 were synthesized by
Dharmacon, USA. siRNA-PARN (50-GGAUGUCAUGCAUACGAUUtt-30),
EXOSC5 (50-UCUUCAAGGUGAUACCUCUtt-30) and XRN1 (50-GAGGUGU
UGUUUCGAAUUAtt-30) were acquired from Ambion, USA.
Preparation of cell extracts and immunoblotting. Total cell extracts were
prepared52 and western blot was performed using antibodies against HuR (3A2,
1:10,000)53, NPM (anti-B23 clone FC82291, Sigma-Aldrich, 1:30,000), My-HC
(Developmental studies Hybridoma5, 1:1,000), Myoglobin (DAKO, 1:500),
a tubulin (Developmental studies Hybridoma Bank, 1:1,000), GFP (Clontech,
Mountain View, CA, USA, 1:1,000), and KSRP (afﬁnity-puriﬁed rabbit serum17,
1:3,000), anti-myogenin (F5D, obtained from Developmental Studies Hybridoma
Bank, 1:250) and caspase 3 cleavage product (Cell Signaling Technology, 1:1,000).
Scans of the most important blots are shown in Supplementary Fig. 15.
Immunoﬂuorescence. Immunoﬂuorescence5 was performed to detect GFP
expression as well as to visualize myotubes using antibodies against My-HC
(1:1,000) and Myoglobin (1:500). Staining with 40 ,6-diamidino-2-phenylindole
(DAPI) was employed to visualize nuclei.
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Fusion index. The fusion index5 indicating the efﬁciency of C2C12 differentiation
was determined by calculating the number of nuclei in each microscopic ﬁeld in
relation to the number of nuclei in myotubes in the same ﬁeld.
Northern blot analysis and actinomycin D pulse-chase experiments. The
extraction of total RNA from C2C12 cells was performed using Trizol reagent
(Invitrogen) according to the manufacturer’s instructions. Northern blot analysis23
was performed using probes speciﬁc for MyoD, HuR, 18S48 and NPM
(Supplementary Table 2). These probe RNAs were generated using the PCR
Puriﬁcation Kit (GE Healthcare) and radiolabelled with a32P deoxycytidine
triphosphate (dCTP) using Ready-to-Go DNA labelling beads (GE Healthcare)
according to the manufacturer’s instructions. The stability of NPM mRNA was
assessed by the addition of the transcriptional inhibitor actinomycin D (5 mgml 1;
Sigma-Aldrich)48 for the indicated periods of time.
RT-qPCR. 1 mg of total RNA was reverse transcribed using the M-MuLV RT
system. A 1/80 dilution of cDNA was used to detect the mRNAs using SsoFast
EvaGreen Supermix (Bio-Rad). Expression of NPM, MyoD, p21, myogenin and
RLuc was standardized using GAPDH as a reference (see primers in Supplementary
Table 2), and relative levels of expression were quantiﬁed by calculating 2DDCT,
where DDCT is the difference in CT (cycle number at which the amount of
ampliﬁed target reaches a ﬁxed threshold) between target and reference.
Genomic DNA extracts and analysis by RT-qPCR. Cell pellets are resuspended
in the digestion buffer (100mM NaCl; 10mM Tris–HCl, pH 8; 25mM EDTA,
pH 8; 0.5% SDS; 0.1mgml 1 proteinase K) and incubated at 50 C overnight.
Genomic DNA (gDNA) is extracted with phenol chloroform (Invitrogen)
according to the manufacturer’s instructions. RT-qPCR experiment was performed
as described above starting from 16 pg of extracted gDNA.
Immunoprecipitation. Cell extracts were prepared in the lysis buffer (50mM Tris,
pH 8; 0.5% Triton X-100; 150mM NaCl; complete protease inhibitor (Roche)).
When indicated, cell extracts were digested for 30min at 37 C with RNase A
(100 mgml 1). Anti-KSRP serum (2 ml) (afﬁnity-puriﬁed rabbit serum17) was
incubated with 50ml of proteinA-sepharose slurry beads (washed and equilibrated
in cell lysis buffer) for 1 h at 4 C. Beads were washed three times with cell lysis
buffer and incubated with 300 mg of cell extracts overnight at 4 C. Beads were
washed three times with cell lysis buffer and co-immunoprecipitated proteins were
analysed by western blot. HuR, PARN and EXOSC5 IP were performed3,5,54 using
antibodies against HuR (3A2), PARN (Cell Signaling, USA), EXOSC5 (Abcam,
USA) and IgG (Jackson Immunoresearch Laboratories, USA).
Preparation of mRNA (mRNP) complexes and analysis by RT-PCR. Puriﬁed
RNA from mRNP complexes5,54 was resuspended in 10ml of water and 4 ml was
reverse transcribed using the M-MuLV RT system (NE Biolabs) according to the
manufacturer’s protocol. Subsequently, 2 ml of cDNA was ampliﬁed by PCR or
qPCR using NPM-speciﬁc primers (Supplementary Table 2). When analysed by
qPCR, a 1/20 dilution of cDNA was used to detect the mRNAs using SybrGreen
(SsoFast EvaGreen Supermix). The mRNA levels associated with these mRNP
complexes were then standardized against RPL32 mRNA levels (used as a
reference) and compared with mRNA levels in the IgG control. In experiments
transfected with Rluc reporter constructs, the Rluc mRNA associated with
immunoprecipiated HuR was determined by RT-qPCR, standardized against
RPL32 mRNA levels and then the steady-state levels for each treatment. These
standardized Rluc mRNA levels were then compared with Rluc mRNA levels in
the IgG IP.
cDNA array analysis. Microarray experiments were performed using mouse
array, which contain probe sets of characterized and unknown mouse expressed
sequence tags (ESTs) from 17,000 genes55. RNAs from siHuR- and siCtr-treated
C2C12 cell extracts were prepared56, processed and hybridized on the arrays. The
data were processed using the Array Pro software (Media Cybernetics), then
normalized by Z-score transformation55 and used to calculate differences in signal
intensities. Signiﬁcant values were tested using a two-tailed Z-test and a P-value of
r0.01. The data were calculated from two independent experiments.
Fluorescence in situ hybridization. The ﬂuorescence in situ hybridization
experiments were performed57 using a DNA fragment of B500 bp corresponding
to the coding region of mouse NPM. The fragment was ampliﬁed by PCR using the
following primers fused to either a T7 or T3 minimal promoter sequence: NPM
forward, 50-TAATACGACTCACTATAGGGACGGTTGAAGTGTGGTTCAG-30
and NPM reverse, 50-AATTAACCCTCACTAAAGGAACTTGGCTTCCACTT
TGG-30 . The PCR product was used as the template for in vitro transcription of the
NPM probe needed for ﬂuorescence in situ hybridization. The antisense (T3) and
sense (T7) probes were prepared using digoxigenin-RNA labelling mix (Roche
Diagnostics). The RNA probes were quantiﬁed, denatured and incubated with
permeabilized cells57. After the hybridization, the cells were used for
immunoﬂuorescence to detect HuR57.
Polysome fractionation. A total of 4 107 myoblasts were grown and treated with
siRNAs as described above. Brieﬂy, the cytoplasmic extracts obtained from lysed
myoblast cells were centrifuged at 130,000 g for 2 h on a sucrose gradient (10–50%
w/v)58. RNA was extracted using Trizol LS (Invitrogen), and was then analysed
on an agarose gel. The levels of NPM and GAPDH mRNAs were determined by
RT-qPCR.
RNA electrophoretic mobility shift assays. The NPM cRNA probes were pro-
duced by in vitro transcription59. The accession number in the NCBI database of
the NPM mRNA sequence used to generate these probes is NM_008722. The NPM
probes 50-UTR, 30-UTR, P1 and P2 were generated by PCR ampliﬁcation using a
forward primer fused to the T7 promoter (Supplementary Table 2) as well as
pYX-Asc-NPM expression vector as the template. For smaller probes (P1-1 to
P2-3, P1-1-mut1, P1-1-mut2, P1-1-mut1-2), oligonucleotide sense and antisense
(see Supplementary Materials and Methods) were directly annealed and used for
in vitro transcription. The RNA-binding assays23 were performed using 500 ng
puriﬁed recombinant protein (GST or GST-HuR) incubated with 50,000 c.p.m.
of 32P-labelled cRNAs. Supershift experiments were also performed with 10 mg
total C2C12 cell extract incubated with 50,000 c.p.m. of 32P-labelled cRNAs.
An anti-KSRP antibody was then added to the reaction to supershift the
RNP/cRNA complex containing KSRP.
Luciferase activity. The activity of Renilla luciferase was measured using a
Renilla luciferase assay system (Promega) with a luminometer following the
manufacturer’s instructions.
In vitro pull-down experiments. GST pull-down assay4 was performed using
GST-HuR and recombinant His-KSRP. The interaction of the His-KSRP with the
pulled-down GST-HuR was analysed by western blot using the GST and KSRP
antibodies.
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